Springer Science+Business Media, Dordrecht, 2016. — 1240 p. — ISBN10: 9400776772
Transcends the intellectual-divide with Key Facts (areas of focus explained for the lay person), Definitions 0f Words and Terms, and Summary Points.
Wide applicability with each chapter containing a section called Potential Applications To Prognosis, Other Diseases or Conditions.
Authoritative text by leading experts.
Links conventional approaches with new platforms.
Holistic coverage of material with over 50 chapters.
On an annual basis, over 17 million people die due to cardiovascular disease. This represents a third of all global deaths. The World Health Organisation have identified cardiovascular disease as the leading cause of death worldwide. Although many cardiovascular conditions are preventable, there is a need for accurate characterisation and diagnosis of cardiovascular conditions before, during and after treatments. Much of this characterisation entails the use of biological indicators, i.e biomarkers. Biomarkers in Cardiovascular Disease combines detailed information on different cardiovascular conditions and the concomitant application of conventional, new and emerging biomarkers. It covers the latest knowledge, trends and applications. New platforms are described which combine advances in biomedical sciences, physics, computing and chemistry.
TopicsCancer Research
Oncology
Pharmacology / Toxicology
In the present volume,
Biomarkers in Cardiovascular Disease, we have sections:
General Aspects
Circulating and Body Fluid Biomarkers
Specific Diseases and Conditions
Molecular, Cellular, and Histological Variables
Functional and Structural Variables